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ABSTRACT (MALAY) 
TAJUK 
Kajian preliminari imbasan perfusi tomografi berkomputer di kawasan penumbra bagi 
pesakit hipertensi dengan pendarahan di otak. 
PENGENALAN 
Hipertensi adalah masalah kesihatan utama di Malaysia dengan prevalen sebanyak 24% 
(Zaher et al., 1998) dan pendarahan otak (ICH) adalah komplikasi yang boleh menyebabkan 
kematian atau ketidakupayaan besar berbanding penyakit infaksi otak (Broderick et al., 
1993). 
Imbasan tomografi berkomputer tanpa menggunakan contras (NECT) adalah modaliti 
pengimejan utama untuk mendiagnos ICH. Terdapat percanggahan pendapat samada 
rawatan medikal atau pembedahan memberi kebaikan kepada pesakit. Imbasan perfusi 
tomografi berkomputer (CTP) membolehkan perfusi otak dikaji. Ini secara teorinya boleh 
diguna untuk pemilihan rawatan medikal atau pembedahan. 
Barthel index yang diubah (MBI) adalah skala ketidakupayaan yang boleh dipercayai 
(Suiter et al., 1999) dan diguna sebagai penilai hasil. 
OBJEKTIF 
Kajian preliminari ini bertujuan mengenalpasti corak perfusi sekeliling darah beku and 
hubungkait dengan hasil klinikal. Ini akan diguna sebagai menjangka hasil akhir samada 
rawatan secara medikal atau pembedahan memberi kebaikan kepada pesakit. Kajian ini juga 
untuk mengenalpasti faktor penyebab ketidaknormalan perfusi di keliling darah beku dalam 
xii 
ICH dan untuk mengenalpasti faktor penyumbang kepada hasil klinikal dalam pesakit ICH 
hipertensi. 
BAHAN DAN KAEDAH 
Dari Julai 2004 hingga November 2005, 10 pesakit telah dianalisa apabila kriteria 
peryertaan dipenuhi dan persetujuan bertulis diberi. 
Imbasan NECT dijalankan untuk memastikan diagnosis ICH kemudian CTP dijalankan. 
Data dianalisa di 'CT workstasion'. Isipadu dan jarak darah beku dari tempurung kepala 
dikira di dalam imbasan NECT. Kawasan keliling darah beku dibahagi kepada 4 bahagian 
berdasarkan jarak dari tempurung kepala. Kawasan yang ingin dikaj i di lukis berdasarkan 
peta warna CTP. Setiap parameter perfusi dihasiJkan oleh perisian perfusi dan dianalisa 
samada kawasan tersebut mempunyai perfusi yang normal, penumbra atau umbra. 
MBI di nilai sewaktu presentasi dan pada minggu keempat. 
KEPUTUSAN 
Perhubungan Spearman di antara umur dengan MBI sewaktu presentasi dan di antara 
isipadu darah beku dengan jarak dari tempurung kepa]a adalah ketara pada tahap 0.05 (2-
taiJed). Perhubungan Pearson antara isipadu darah beku dengan kecederaan iskemia adalah 
ketara pada tahap 0.01 (2-tailed). Terdapat kecederaan iskemia di kawasan keliling darah 
beku tetapi tiada hubungan secara statistik dengan keadaan klinikal. 
KESIMPULAN 
CTP adalah kaedah yang berguna, mudah dan praktikal bagi menilai perfusi keliling darah 
beku. Ketiadaan hubungan secara klinika1 di dalam kajian ini berkemungkinan besar 
disebabkan jumlah kajian yang kecil. 
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ABSTRACT (ENGLISH) 
TOPICS 
Preliminary study of CT perfusion of penumbra in patient with hypertensive intracranial 
haemorrhage 
INTRODUCTION 
Hypertension is a major illness in Malaysia with a prevalence of 24% (Zaher et al., 1998) 
and haemorrhagic stroke is its complications which much more likely to result in death or 
major disability than cerebral infarction(Broderick et al., 1993). 
Nonenhanced Computed Tomography (NECT) scan is the most common imaging modality 
used to diagnose intracranial haemorrhage (ICH). There were controversial issues whether 
medical or surgical treatment benefits these patients. CT perfusion (CTP) allowed the study 
of cerebral perfusion. TheoreticalJy it is useful in selecting for treatment option. 
Modified Barthel index (MBI) was a reliable disability scale (Suiter et al., 1999) and used 
as outcome assessment. 
OBJECTIVE 
This preliminary study was aimed to determine perfusion characteristics of perihaematoma 
region and correlation with clinical outcome. These will be used as predictor of the outcome 
whether medical or surgical treatment benefits the patients. This study also aimed to find 
contributing factors of abnormal perfusion in perihaematoma of hypertensive ICH and 
factors affecting its clinical outcome. 
xiv 
MATERIAL AND METHOD 
From July 2004 till November 2005, I 0 patients were enrolled as they fulfilled the inclusion 
criteria and written informed consent obtained. 
NECT scan was done to confirm ICH then CTP was performed. The data were analyzed at 
the CT workstation. Haematoma volume and distance from skull were measured in NECT 
scan. Perihaematoma regions were divided into four sections in relation to distance from the 
skull. The regions of interest were drawn based on CTP colour mapping. Each parameters 
of perfusion were produced by the perfusion software and were analyzed whether selected 
region were normal, penumbra or umbra perfusion status. MBI was scored at presentation 
and 4 weeks. 
RESULT 
Significant statistical Spearman correlation at the 0.05 level (2-tailed) noted between ages 
and initial MBI, and haematoma volumes with haematoma distances to skull. Significant 
Pearson correlation of haematoma volume and ischaemic injury sizes at the 0.01 level (2-
tailed) noted. 
Perfusion ischaemic injury were found in perihaematoma region however no statistical 
correlation of the perihaematoma area with clinical outcome. 
CONCLUSION 
CTP is a useful, easy and practical method in assessing intracranial perihaematoma 
perfusion however no correlation with clinical outcome. A bigger sample size may reverse 
these findings. 
XV 
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1. INTRODUCTION 
Hypertension is one of major chronic illness in developed and developing country. This 
disease causes several complications including hemorrhagic stroke. Currently, stroke 
imaging requirement has been increased tremendously due to new and more advance 
treatment. Previously, the managements of stroke were mainly conservative; therefore, 
conventional plain CT scan of the brain was the primary imaging modality. This is true 
especially in the ischaemic stroke when hemorrhagic stroke is needed to be excluded before 
starting thrombolytic agents. 
In hemorrhagic stroke, plain conventional CT scan of the brain is adequate for the 
diagnosis. The examination is fast, reliable and available 24 hours a day in our hospital. At 
present, there is no consensus among the neurosurgical community regarding its optimal 
treatment (Tan et al., 2001). 
The main treatment for hemorrhagic stroke is surgical removal of the blood clot; however, 
surgical intervention is not without a risk. This includes the effect of the anesthetic drugs 
and surgical techniques. Furthermore there are haemodynamic changes within the brain due 
to irritation and compression by the blood product within the brain parenchyma. Post-
operatively, patient also has a risk of rebleeding. About 3.9% of patient had medium or 
large rebleeding after surgery (Fukamachi et al., 1985). It is undecided whether surgical 
evacuation of the haematoma or conservative management would result in better outcome 
(Tan et al., 200 I). The international surgical treatment of intracerebral haemorrhage 
(ISTICH) multi-centre trial study noted that no benefit in early surgery compare with 
conservative treatment (Mendelow et al., 2005) 
Special Writing Group of the Stroke Council, American Heart Association (Broderick et al., 
1999) have recommend indicator for surgical treatment of Intracranial Hemorrhage such as: 
1. Patients with cerebellar hemorrhage >3mls who are neurologically deteriorating 
or who have brain stem compression and hydrocephalus from ventricular 
obstruction should have surgical removal of the hemorrhage as soon as possible. 
2. ICH associated with a structural lesion such as an aneurysm, arteriovenous 
malformation, or cavernous angioma is treated if a patient has a chance for a 
good outcome and the structural vascular lesion is surgically or endovascularly 
accessible. 
3. Young patients with a moderate or large lobar hemorrhage who are clinically 
deteriorating. 
Blood clot within the brain parenchyma will cause compression, irritation and chemical 
changes of surrounding the brain tissue which might cause impairment of perilesional blood 
perfusion. 
The more advance technique of CT scan such as CT perfusion, allows detection of cerebral 
ischaemia; identification of penumbra area and provides valuable information on the extent 
of perfusion disturbance (Koenig et al., 1998). In comparison with other imaging modalities 
such as xenon CT, SPECT, PET or MR Perfusion, CT perfusion has lower cost and more 
practical. It can be performed immediately after plain CT scan without repositioning of the 
patient with fast acquisition time (Eastwood et al., 2002). Perfusion CT studies of CBF 
achieved with adequate acquisition parameters and processing lead to accurate and reliable 
results (Wintermark et al., 2001 ). 
2 
Perihemorrhagic ischaemia may be a potential surrogate indicator to identify patients who 
will benefit from surgical removal of blood clot (Bullock et al., 1984). This will reduce 
patient's morbidity and mortality. This is an art of imaging; CT perfusion is currently 
applicable with our spiral high speed GE CT scan machine and GE CT perfusion software. 
Modified Barthel index is functional assessment by assessing daily activity. It is a valid 
measure of disability (Collin et al., 1988). It measures parameters of personal hygiene, self 
bathing, feeding, toileting, stair climbing, dressing, bowel control, bladder control, 
ambulation and chair/bed transfer. Each parameter was scored and cumulative score will 
indicate dependency level. The higher the score, less dependent is the patient. These score 
were used in this study as assessment progression after treatment, either surgical or 
conservative. 
Currently not many published data is available in using CT perfusion in assessing 
intraparenchyma cerebral haemorrhage as an indicator for the choice of treatment or 
prediction of clinical outcome. 
Thus, this dissertation project aims to established pattern of perfusion in hemorrhagic stroke 
and the correlation with functional ability. Thus the findings will help in objectively 
measured the patient conditions and whether surgery is indicate. 
A significant correlation of CT perfusion and Modified Barthel index will provide valuable 
prognostic information in management of hypertensive intracranial haemorrhage and 
improve usage ofCT perfusion in evaluation and treatment in these patients. 
3 
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2. LITERATURE REVIEW 
2.1. INCIDENCE 
The prevalence of hypertension in adult population found at screening ranges from 15-25%. 
In Malaysia a recent survey (the National Health and Morbidity Survey II) indicate a 
prevalence of24% (Zaher et al., 1998) 
Stroke is major cause of disability in developing and developed country. In United States 
of America, about 600,000 people suffer a stroke each year; 85% of them first attacks and 
15% recurrent attacks (Dato' Chuah Jui Meng, 2002, Meng, 2002) 
Haemorrhagic stroke is one of the complications of hypertensive disease. Control of 
elevated blood pressure has contributed to reduce in morbidity and mortality from stroke 
(Zaher et al., 1998). Intracerebral hemorrhage (ICH) is more than twice as common as 
subarachnoid hemorrhage (SAH) and is much more likely to result in death or major 
disability than cerebral infarction or SAH (Broderick et al., 1993). 
Every year about 2,500 deaths and 12,000 stroke discharges are recorded in government 
hospitals (Jusoh et al., 2000). In Kuala Lumpur Hospital (KLH) 1,000 stroke cases are seen 
per year with 30-35% acute mortality (Jusoh et al., 2000). Ischaemic stroke seen in 67% of 
stroke cases and 33% were due to haemorrhage (Jusoh et al., 2000). Local study of 
spontaneous ICH conducted at Hospital University Science Malaysia (HUSM) revealed 
22% of all stroke were haemorrhagic in origin and hypertension is the most important risk 
factor for ICH (Muiz et al., 2003). Another study for Malaysian population revealed that 9-
31% of stroke was hemorrhagic (Ong and Raymond, 2002). 
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The worst prognosis in cerebral haemorrhage is acute mortality rate of 60-80% which is 
higher than seen infarction stroke about 20-40% (Jusoh et al., 2000). A study in HUSM 
noted, 25% mortality rate by 3 months, 58.9% poor final outcome, and 4I.I% had a good 
outcome (Muiz et al., 2003). 
2.2. DEFINITIONS 
Stroke is a clinical symptom when there is a sudden loss of brain function caused by a 
blockage or rupture of a blood vessel to the brain, characterized by loss of muscular control, 
diminution or loss of sensation or consciousness, dizziness, slurred speech, or other 
symptoms that vary with the extent and severity of the damage to the brain. It is also called 
cerebral accident, or cerebrovascular accident. 
Hypertension is defined when systolic pressure above I40mmHg and diastolic pressure 
above 90mmHg (Zaher et al., I998). It can be categorized as mild (systolic I40-I59mmHg 
diastolic 90-99mmHg), moderate (systolic I60-I79mmHg diastolic I 00-I 09mmHg), severe 
(systolic I80-209mmHg diastolic II O-II9) and very severe (systolic >2I OmmHg, diastolic 
> 120mmHg). Hypertension should not be diagnosed on the basis of a single measurement 
unless there is a target organ damage or systolic blood pressure >21 OmmHg or diastolic 
blood pressure > I20mmHg (Zaher et al., 1998). 
CT perfusion is a functional imaging showing changes in how parts of the brain tissue 
behave over time, particularly the density of blood product in those tissues. Contrast media 
is used, injected intravenously. Changes of various perfusion parameters over a short period 
of time are calculated. The parameters are cerebral blood flow (CBF), cerebral blood 
volume (CBV) and mean transit time (MIT). 
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Cerebral Blood Flow (CBF) is defined as the volume flow of blood through vasculature 
including the large conductance vessels, arteries, arterioles, capillaries, venules, veins and 
sinuses in a given brain volume in a given time. Units: ml/min/1 OOg. (Cullen et al., 2002) 
Cerebral Blood Volume (CBV) is the volume of blood in the vasculature including the large 
conductance vessels, arteries, arterioles, capillaries, venules, veins and sinuses in a given 
brain volume. Units: ml/1 OOg (Cullen et al., 2002). 
Mean Transit Time (MTT) is blood traverses the vasculature through different path lengths 
such that there does not exist in a unique transit time from the arterial inlet to venous outlet. 
Instead there is a distribution of transit times and the mean transit time is the mean time of 
such a distribution. 
Penumbra is the areas adjacent and surrounding the haematoma which has perfusion less 
than normal but higher than infarction values. It is an area of ischaemic viable tissue. If the 
tissues become infracted or non-viable, it is called umbra area. 
2.3. PATHOLOGY/PATHOGENESIS 
Hypertension is among the commonest causes of atraumatic cerebral hemorrhage in adults 
(Bagley, 1999, Ong and Raymond, 2002). Hypertensive hemorrhages typically occur within 
the putamen, thalamus (Bagley, 1999, Tan et al., 2001, Hsiang et al., 1996), external 
capsule, and posterior fossa, particularly pons and cerebellar hemispheres (Bagley., 1999). 
In hemorrhagic stroke, haematoma will be formed within brain parenchyma. This causes 
increase in perilesional pressure gradient and limits the extent of haemorrhage. This 
pressure gradient will cause compression to the microcirculation. Haematoma also will 
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cause reduction in regional cerebral blood flow (Mendel ow et al., 1984, Xi et al., 200 I) 
with production of chemical vasoconstriction (Mendelow et al., I984). These effects will 
cause perilesional ischaemic changes and brain cell changes. Acidosis, edema, potassium 
and calcium ions transit and inhibition of protein synthesis may contribute to cerebral 
ischaemia (Siesjo., I992). This is seen as marked swelling of astrocytes particularly 
perivascular astrocytic foot processes on electron microscope (Bullock et al., 1984). 
The time when the surgery is performed is also important. Red blood cells (RBCs) 
constituents such as hemoglobin and its degradation products (oxyhemoglobin, 
deoxyhemoglobin or methemoglobin) those appear after delayed lysis, increase blood-brain 
barrier permeability, contributing edema formation. Oxyhemoglobin is a spaminogen (Xi., 
2001) and also can induce apoptosis in cultured endothelial cells and apoptosis has been 
found in intracerebral haemorrhage (Ogihara et al., I999, Matsushita et al., 2000, Gong et 
al., 200I). This can occur when the cerebral blood flow value is IO-ISml/min/IOOg causing 
failure of energy dependent sodium pump. This leads to accumulation of intracellular 
sodium and water shift into the cells causing neuronal swelling leading to cytotoxic 
oedema. This edema causes leakage from epithelial lining of capillaries leading to 
vasogenic edema 6 hours after ischaemic event. Cerebral edema increases intracranial 
pressure and further compromises the blood supply to the brain parenchyma. 
Thrombin has been implicated in brain injury and edema formation after intracerebral 
hemorrhage. Erythrocyte lysis causes marked blood brain barrier disruption and increases 
blood brain barrier permeability to II fold. This causes significant entry of prothrombin 
into brain (Xi et al., 2001 ). If activated factor X is present, an efflux of prothrombin results 
in the generation of thrombin within the brain, leading to edema formation. 
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Perilesional edema on CT scan images always corresponded topographically with perfusion 
deficits on SPECT (Mayer et al., 1998). 
In hypertensive patients, degenerative changes occurred such as perivascular micro infarcts, 
lacuna formation, sub adventitial vascular micro hemorrhages, and fibrinoid vessels 
necrosis(Bullock et al., 1984).This may worsen the ischaemic insult. 
Infarction occurs in all of the patients with cerebral blood flow (CBF) reduction of more 
than 70% and in half of the patients with CBF reduction of 40% to 70% (Mayer et al., 
2000). Although vulnerable neurons may undergo selective injury with mild degrees of 
ischaemia, many cells will survive for significant period of time with reductions in cerebral 
blood flow of up to 40% of normal (Cullen et al., 2002). At this level of reduced perfusion, 
neurons have ceased to function normally and become electrically silent, no longer 
releasing neurotransmitters, but have not undergone cell death (Cullen et al., 2002). This 
region is called ischaemic penumbra area. Normal autoregulation mechanism will lead to an 
increase in cerebral blood flow and mean transit time. Restoration of blood flow to 
penumbra ischaemic area will reverse the ischaemic injury. (Cullen et al., 2002). In umbra 
area (non-viable ischaemic tissue), the autoregulation mechanism is abolished so that both 
cerebral blood flow and cerebral blood volume are reduced with a normal mean transit time. 
To preserve this vulnerable (penumbra) area, surgical intervention might be useful to 
release the pressure on adjacent blood vessels. 
However, surgical evacuation of long standing intracerebral haematoma may establish 
reperfusion of a large zone of perilesional ischaemic tissue, thus worsening edema and 
possibility neurological status(Bullock et al., 1988). 
8 
2.4. CONVENTIONAL CT SCAN IMAGING IN HEMORRHAGIC 
STROKE 
Conventional computed tomography (CT) is the main and primary imaging modality being 
performed for diagnosis of intracranial and intracerebral haemorrhage (Jager and Saunds, 
2001). The acute haematoma will appear as increased radiodensity on CT and reaches 
around 100 HU (Chang et al., 2004, Jager and Saunds, 2001). The increased density of 
blood in relation to the surrounding parenchyma of the brain relates to the hemoglobin 
protein contained in extravasated blood (Chang et al., 2004 ). 
The site of haematoma may give a clue for the causes. The basal ganglia or thalamic bleed 
in hypertensive patient is suggestive of hypertensive intracranial bleed. No further 
investigation require unless the cause is not obvious. This may require CT angiogram or 
reconstruction images. The mass effect, perilesional oedema and intraventricular 
haemorrhage are the common accompanying features. These may cause further injury to 
brain parenchyma. 
Its CT density depends on the initial haemoglobin level, dilution by extracellular fluid and 
partial volume effects. Very rarely haematomas can be isodense to surrounding brain, in 
severely anaemic patient with haematocrit of20% or less (Jager and Saunds, 2001). 
Acute intracerebral clot is usually rounded and homogenously radiodense. Therefore the 
assessment of the size of haematoma is easily done and reliable in estimating the clot 
volume. 
In deep seated or extensive intracranial haemorrhage, blood frequently leaks into ventricles 
where it may adhere to the ependyma or to the choroids plexus; alternatively, it can sink to 
the most dependent part of ventricular system, usually the occipital horn, forming a fluid 
level within the ventricular fluid (Jager and Saunds, 2001). 
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The high attenuation of an acute intracranial bleed on CT may persist for approximately I 
week (Chang et al., 2004). Over the course of several days, an untreated haematoma 
becomes less radiodense, from periphery towards the centre, and appears smaller. After 
several weeks, the CT density of blood products can be similar to that of the brain or CSF 
(Jager and Saunds, 200 I). 
Figure 2-1: Right putaminal hemorrhage on NECT examination of the head. 
Tiny hyperdense foci in the basal ganglia and pineal gland represent calcifications. 
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Figure 2-2: NECT examination of the head showed a large right cerebellar 
hemorrhage. 
Plain CT scan is also used for reassessment of the post operative bleeding especiall y when 
there is reduction in the conscious level or when the expected recovery did not ach ieve. 
However, post operative CT scan findings were not used as a predictor factor of the 
outcome in this study 
2.5. CT PERFUSION IN CEREBROVASCULAR ACCIDENT 
In 1971 , Godfrey Hounsfields introduced CT scan. Eight years later, in 1979, Leon Axel 
first proposed a method for determination tissue perfusion from dynamic contrast enhanced 
CT data. This needs rapid image acquisition and processing, which was not widely avai lable 
at that time. This factor limited CT perfusion to only research for renal or myocardial blood 
flow using electron beam CT system. Nowadays, since advent of spiral CT systems in 
11 
1990s, CT perfusion was able to be performed with conventional CT system. The 
development of the multislice CT systems has increase of the use of CT perfusion with 
more advance technique from single-slice technique to a volume-based technique. 
Nowadays, with the availability of more commercial software packages from a range of CT 
manufactures, the clinical usage of CT perfusion had increased. 
Currently the most common clinical applications of CT perfusion are in acute stroke and 
oncology which stimulating by the development of new therapeutic options such as 
thrombolysis in acute stroke and anti-angiogenesis therapy for tumour (Miles and Griffiths, 
2003). In evaluating ischaemic stroke tissue, perfusion values must be related to known 
ischaemic threshold, and hence absolute quantification in terms of volume of blood flowing 
per unit of tissue is essential. This is different in setting for tumour perfusion, which 
exploits the increase in perfusion that result from tumour neovascularization. However, the 
perfusion in a tumour vascular bed is also affected by the cardiac output and thus perfusion 
parameters that correct for cardiac output may reflect the density of vascular bed more 
directly than absolute perfusion value. 
Conventional CT is used widely in assessing patient with acute stroke, which classically is 
to exclude intracerebral haemorrhage. However, 85% of stroke patients were ischaemic in 
origin and majority of the patients were scanned within first 6 hours. These cases revealed 
normal or subtle abnormalities that are easily undetected. The usage of CT perfusion had 
increased the detection of ischemic area which only required 50mL of contrast media and 
CT perfusion scan was completed in less than 5 minutes time. This reduces the time delay 
for further investigation with additional modalities in diagnosing acute stroke therefore 
necessary treatment can be given immediately. 
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Neuronal function is critically dependent upon blood flow and the brain has an 
autoregulation system of controls for maintenance of cerebral perfusion. This autoregulation 
is reflected in the perfusion CT findings in patient with cerebral ischemia. Slight reduction 
of cerebral blood flow of ischaemic brain parenchyma will be compensated by increase in 
blood volume to respective region. The mean transit time also will be increased. When the 
ischemic injury is prolonged, the autoregulation will be impaired causing reduction of both 
cerebral blood flow and cerebral blood volume with or without prolong mean transit time. 
This causes ischemic brain tissue to be infracted. 
Table 2-1 :Summary of perfusion parameters in ischaemic injury (Miles and 
Griffiths, 2003) 
CBF CBV MTT 
Autoregulatory range N + + 
Oligemia (misery perfusion) - ++ ++ 
Ischaemia (metabolic impairment) - + ++ 
Irreversible damage( necrosis) -- - -I+ 
N:normal, +:raised, -:decreased 
In most cases of hemorrhagic stroke, there will be reduction of hounsfields unit in 
perihaematoma area in comparison to the surrounding brain parenchyma. This area was 
considered as area of cerebral oedema secondary to injury by the haematoma. It also 
considered as area of hypoperfusion since the oedema can cause compression on the 
vasculature bed leading to ischaemic injury. Rosand et al. (2002) reported that there was 
most pronounce reduction of cerebral blood flow immediately adjacent to the haematoma. 
The ischaemic injury is as seen in thrombosis stroke. In patients with hypertensive 
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intracerebral haemorrhage, the reduction of blood pressure may aggravate the 
hypoperfusion injury of perihaematoma area in spite of limiting haematoma expansion 
(Rosand et al., 2002). 
Perfusion CT is also used in other than systems such as oncology. The basis for CT 
perfusion in oncology is that the micro vascular changes in angiogenesis (process of 
neovascularization) are reflected by increased tumour perfusion in vivo and this is essential 
for the tumoural growth and determined the ability of tumours to metastasis. Current CT 
protocols for tumours with CT perfusion provide information of incremental benefit in 
diagnosis, staging, assessment of tumour grade and prognosis, and therapy monitoring. 
The determination of tissue perfusion using CT is based on examining the relationships 
between the arterial, tissue and potentially the venous enhancement after the introduction of 
a bolus of contrast material. Repeated rapid CT scans are acquired at the same location to 
allow determination of time-attenuation curves (T AC). Several methods have been 
developed to obtain perfusion values and been made commercially available by the major 
CT vendors together with CT scan machine such as in our hospital which we have it from 
General Electric company. All the techniques are based on the intravenous administration of 
iodine based CT contrast material and the change in attenuation due to this contrast material 
is directly proportional to the enhancement, expressed as aCT number or Hounsfields Unit 
(HU), can be directly used in tracer based techniques. The series of images obtained as the 
bolus of contrast material washes into and out of the tissue must contain at least one non 
contrast-enhanced image to act as a baseline. The baseline image is subtracted either on a 
pixel by pixel or regional basis, from the remaining image set to obtain time enhancement 
data. The use of regions of interest allows the generation of organ, regional or pixel time 
enhancement curves. 
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Few factors may degrade CT perfusion images, thus perfusion values. The major limitation 
is the limited sample volume. This leads to only limited section of organ of interest can be 
studied. Patient movement during repeating scanning of the same tissue volume over 
extended periods of time will cause error in perfusion values. Breathing movement will be a 
continuing problems in spite of instruction to patients especially perfusion involving 
respiration region such as lung nodule. Beam hardening artifact can affect the perfusion 
values. The typical tissue enhancement in CT perfusion is of the order of I OHU. 
There was a variation in cardiac output in every individual. This caused variation of 
perfusion in individual people. Therefore the suitable method to detect perfusion defect was 
by comparing between perfusion parameters in left and right cerebral hemisphere at the 
same anatomical area. However, a variation in size of right and left intracerebral arteries 
(ICA) in different individual also present thus might cause a variation in blood volume 
arrived to both cerebral hemispheres. This might cause slight different of perfusion in left or 
right cerebral hemisphere. Presuming good cross supply through communication arteries, 
therefore the perfusion between both cerebral hemispheres won't be affected. 
2.6. CURRENT MANAGEMENT IN HEMORRHAGIC STROKE. 
The most important step is to make a correct diagnosis of the hemorrhagic stoke. Several 
other causes may appear as hypertensive intracerebral hemorrhagic stoke. This is due to 
physiological effect of the intracranial vascular channels to maintain the blood flow to the 
brain parenchyma leading to increase in blood pressure. Vascular malformation such as 
aneurysm or arteriovenous malformation may present classically with subarachnoid 
haemorrhage. Intraparenchyma bleed at unusual site for hypertensive bleed such as 
perisylvian haemorrhage, abnormal intracranial calcification, prominent vascular structures 
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are other presentations of vascular malformation (Broderick et al., 1999). Haemorrhage into 
cerebral infarction area is also common. This can be differentiating by detail clinical history 
and plain CT scan findings. Intracranial haemorrhage usually presented by severe headache 
(Broderick et al., 1999) before unconscious associated with vomiting (Broderick et al., 
1999) and the weakness usually global. Plain CT scan will revealed predominant 
hyperdense area as a bleeding area. Another cause mimicking hypertensive intracerebral 
haemorrhage is tumour bleeding, however the usual history is chronic headache with early 
morning vomiting and CT will revealed heterogeneous hyperdense area with tumour tissue 
in the outer layer. Contrast enhanced CT scans will be helpful. Sometimes there is an 
associated skull vault change. 
The hypertensive intracerebral haemorrhage management is either medical or surgical 
management. Medical management includes initial acute management of airway, breathing 
and circulation, and detection of focal neurological deficits(Broderick et al., 1999). Patient 
who decreased in conscious level are candidates for aggressive airway management 
including intubation. Blood pressure was recommended to maintained below 
130mmHg(Broderick et al., I 999) . Patient who has intracranial pressure (ICP) monitoring, 
cerebral perfusion pressure which was the product of mean arterial pressure (MAP) minus 
ICP (MAP-ICP) should be kept >70mmHg. Mean arterial blood pressure >I OOmmHg 
should be avoided immediately postoperative. Elevated ICP is defined as intracranial 
pressure more or equal to 20mmHg for >5minutes. The therapeutic goal for all treatment of 
elevated ICP is ICP <20mmHg and cerebral perfusion pressure (CPP) >70mmHg. Fluid 
management is also mandatory and central venous pressure (CVP) should be maintained 
between 5- I 2 mmHg and pulmonary wedge pressure about I 0-14mmHg. Electrolytes must 
be in optimum level. Seizures are common and must be treated aggressively. Antiepileptic 
drugs should be used and doses are titrated accordingly. Body temperature should be 
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maintained at normal levels. Acetaminophen 650mg or cooling blankets should be used to 
treat hyperthermia >38.5°C. Other medical treatments are including psychological support 
to patient and family. Depending on patients' clinical state, physical therapy, speech 
therapy, and occupational therapy should be initiated as soon as possible. 
The ideal goal for surgical treatment is to remove as much as blood clots as possible and as 
quickly as possible with the least amount of brain trauma from the surgery itself. It also 
should prevent complications such as hydrocephalus and mass effect of the blood clot. 
Craniotomy is the standard approach for removal of intracerebral haemorrhage. Its major 
advantage is adequate exposure to remove the clot. The major disadvantage is the more 
extensive surgical approach may lead to further brain damage, particularly patient with deep 
seated clot. Endoscopy aspiration of haemorrhage is another technique for clot removal and 
patient with haematoma <50cm3 had better quality of life compare to those treated 
medically(Broderick et al., 1999). 
2.7. MODIFIED BARTHEL INDEX 
The Barthel Index (BI) is commonly used scales to assess outcome and the most commonly 
used scale for assessing activities of daily living and a reliable disability scale for stroke 
patients (Suiter et al., 1999). The maximum patient scoring for modified Barthel index is 
100 (Carroll et al., 1965). 
The items can be divided into group that is related to self-care(feeding, grooming, bathing, 
dressing, bowel and bladder care, and toilet use) and a group related to 
mobility(ambulation, transfers, and stair climbing). The final score will be categorized as 
favorable or poor outcome. This is the drawback of the Barthel index as it is an ordinary 
(noncontiguous) scale. Therefore, parametric statistical method cannot be used (Suiter et al., 
1999). 
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A different in category of disability on BI may allow assessment of a global shift toward 
independence in subsequent categories of scores rather reliance on a single score that 
dichotomizes outcome into favorable or poor. The Modified Barthel Index is a score that 
can give continuous scale and it is also a functional assessment by assessing daily activity. 
It is a valid measure of disability (Collin C et al., 1988). 
The items in Modified Barthel Index includes personal hygiene, bathing self, feeding, toilet, 
stair climbing, dressing, bowel control, bladder control, ambulation or wheelchair and 
chair/bed transfer. Each of the items is scored on basis of the best ability to perform the 
task. It is divided into unable to perform task, substantial help required, moderate help 
required, minimal help required or fully independent and each is given a number values. 
The Modified Barthel Index Total Scores is calculated by the sum of all the items scored. 
The categorization of Modified Barthel Index is based on total scores and categorize into 
1 ,2,3,4 and 5. If patient is dead, he/she is categorized as 0. 
Every patient is assessed using Modified Barthel Index at presentation to hospital and at 
four weeks after presentation and categorized accordingly. This is to assess whether there is 
improvement or worsening in daily living activity after four weeks. 
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3. AIM AND OBJECTIVES 
3.1. GENERAL OBJECTIVE 
The general objective for this study is; 
I. To establish pattern of perfusion in haemorrhagic stroke patients. 
3.2. SPECIFIC OBJECTIVES 
The specific objectives for this study are; 
I. To determine perfusion characteristics of perihaematoma region whether penumbra 
present or not. 
2. To determine correlation between CT perfusion parameters with short term clinical 
outcome at 4 weeks period (This is as a prognostic prediction). 
3. To find contributing factors of abnormal perfusion in perihaematoma of 
hypertensive intracerebral haemorrhage. 
4. To find factors affecting the outcome of the hypertensive intracerebral haemorrhage 
patients. 
3.3. HYPOTHESIS 
3.3.1. Null hypothesis 
1. There is no change of perfusion in perihaematoma area in hypertensive hemorrhagic 
stroke. 
2. Penumbra perfusion cannot be used as a prognostic factor. 
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3.3.2. Alternative hypothesis 
1. There are changes of perfusion in perihaematoma area in hypertensive hemorrhagic 
stroke 
2. The penumbra perfusion can be used as a prognostic predictor. 
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4. RESEARCH DESIGN AND METHODOLOGY. 
This cross-sectional study obtained its ethical clearance from the School of Medical 
Sciences Ethical Committee, Universiti Sains Malaysia in March 2004. The study was 
conducted in Hospital Universiti Sains Malaysia in Kubang Kerian, Kelantan after had 
clearance from hospital director in June 2004. Data were collected from July 2004 till 
November 2005. 
The initial calculation sample size (n) for this study was 50 patients. This was obtained by 
sample size calculation, with precision (6.) = 28% of SD. 
n = Z 2 (~)2 = 1.962 x(-1 ) 2 =50 6 0.28 
Sample size has been determined as 50. Although the optimal sample size should be more 
than 50, it is limited by availability of cases during the study period (less than 2 years). 
With this sample size (50), the obtained precision not worse than 28o/o of the population 
Standard deviations (SD) in calculating 95% confidence intervals (CI) means (If the 
population SD is I 0, the precision will be 2.8). 
Although a detail sample size calculation could not be done for the objective determining 
the relationship between perfusion and the clinical outcomes, probably the detectable 
alternative that the study could detect with the 80% power and the level of significance at 
0.05, would be rather large with above sample size. 
However, this study hopefully will give a preliminary or exploratory result rather than a 
reasonably conclusive result with above sample size. By the end of the study periods, there 
were ten patients involved in this study. 
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4.1. PATIENT SELECTIONS 
This study was conducted in Hospital Universiti Sains Malaysia (HUSM), Kubang Kerian, 
Kelantan. 
4.2. INCLUSION CRITERIAS 
The inclusion criteria for this study were; 
I. All patients with age of 15 years old and above who admitted to our hospital 
(HUSM). 
2. Diagnosed to have hypertensive intracranial haemorrhage. This was confirmed by 
a plain CT scan of the brain which was performed in HUSM. 
3. Patient or legal next-of-kin will give a written informed consent before proceed 
with the study. 
4.3. EXCLUSION CRITERIAS 
Exclusion criteria for this study were; 
1. Patients (or legal next-of-kin) who do not give consent for the study. 
2. Patients who have contraindication for contrasted study (such as allergy to 
sea-food/drug/asthma/pregnant etc.). 
3. Patients who were diagnosed to have subarachnoid haemorrhage, 
intracerebral hemorrhage resulted from underlying vascular malformation, 
hemorrhagic transformation of an ischaemic stroke, vasculitis, tumour or 
trauma. 
4. Patient who have previous stroke within 6 weeks of presentation. 
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When patient fulfi11ed the inclusion criteria and do not have exclusion criteria, CT perfusion 
of the brain wi11 be followed at same setting. This is done by following CT perfusion 
protocol. 
4.4. TECHNIQUE 
Data acquisition was done using a multi detector CT scanner (Light speed; General Electric 
Medical Systems). 
Patient was position with the radiographic baseline perpendicular to the table. A scanogram 
was acquired. Helical plain CT scan of 3.75mm thick basal sections and 7.5mm thick 
supratentorial axial section was obtained. The images were reviewed by senior medical 
officer for present of haematoma and determine the slice location at the level of largest 
bleeding site. Using the angiographic power injector, 50ml of 320mgllml strength iodinated 
contrast media (Visipaque) was introduced into the peripheral vein through an 180 catheter 
at 4ml/s. Scan was delayed for 4s and total scan time was 45s. 
Four sections in one second with the thickness of5mm and image matrix of512 x 512 were 
obtained immediately after plain CT scan. The kilovolt was set at 80 with rnA of 190-200. 
Total 180-200 images were obtained and were sent to workstation for review and post 
processing. 
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4.5. MODIFIED BARTHEL INDEX 
A baseline Modified Barthel index scoring was done by attending doctor at the same setting 
of CT Perfusion according to Modified Barthel Index guideline. A cumulative score was 
determined for each patient at the end of the assessment. 
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